Table 1 Baseline Characteristics of Patients in the Derivation Cohort (n = 250)
From: Early prediction of cerebral-cardiac syndrome after ischemic stroke: the PANSCAN scale
Characteristics |  | no CCS, n = 112 | CCS, n = 138 | P-value |
|---|---|---|---|---|
Age, n (%) | < 65 | 76 (67.9) | 50 (36.2) | < 0.001* |
≥65 | 36 (32.1) | 88 (63.8) |  | |
Sex, n (%) | Male | 70 (62.5) | 56 (40.6) | 0.001* |
Female | 42 (37.5) | 82 (59.4) | Â | |
Stroke location, n (%) | Brain stem | 18 (16.1) | 30 (21.7) | 0.155 |
Others | 94 (83.9) | 98 (71.0) | Â | |
Temperature(°C), n (%) | <37.5 | 98 (87.5) | 118 (85.5) | 0.713 |
≥37.5 | 14 (12.5) | 20 (14.5) |  | |
Mean Arterial Pressure (mmHg), n (%) | Normal(<105) | 44 (39.3) | 60 (43.5) | 0.521 |
Elevated(≥105) | 68 (60.7) | 78 (56.5) |  | |
GCS Score, n (%) | Conscious(15) | 108 (96.4) | 120 (87.0) | 0.027* |
Mild(12 ~ 14) | 2 (1.8) | 12 (8.7) |  | |
Moderate(9 ~ 11) | 0 (0.0) | 4 (2.9) |  | |
Coma(≤8) | 2 (1.8) | 2 (1.4) |  | |
NIHSS Score, n (%) | 0 | 54 (48.2) | 20 (14.5) | < 0.001* |
1 ~ 4 | 44 (39.3) | 60 (43.5) |  | |
> 4 | 14 (12.5) | 58 (42.0) |  | |
Hypertension, n (%) | No | 32 (28.6) | 58 (42.0) | 0.34 |
Yes | 80 (71.4) | 80 (58.0) | Â | |
Diabetes, n (%) | No | 82 (74.5) | 96 (70.6) | 0.567 |
Yes | 28 (25.5) | 40 (29.4) | Â | |
Stroke Times, n (%) | 1 times | 96 (85.7) | 110 (79.7) | 0.245 |
> 1 times | 16 (14.3) | 28 (20.3) |  | |
Smoking history, n (%) | No | 104 (92.9) | 122 (88.4) | 0.284 |
Yes | 8 (7.1) | 16 (11.6) | Â | |
Drinking history, n (%) | No | 72 (64.3) | 98 (71.0) | 0.277 |
Yes | 40 (35.7) | 40 (29.0) | Â | |
WBC(10^9/L), median (IQR) | Â | 6.30 (5.60, 8.18) | 6.75 (5.43, 8.90) | 0.497 |
Neutrophil(%), median (IQR) |  | 61.3 (56.1, 66.1) | 66.0 (59.6, 76.0) | < 0.01* |
PT(s), median (IQR) | Â | 13.0 (12.3, 13.9) | 13.6 (12.8, 15.1) | 0.012* |
APTT(s), median (IQR) | Â | 36.6 (34.4, 38.3) | 37.2 (34.4, 42.0) | 0.031* |
Fibrinogen(g/L), median (IQR) | Â | 3.29 (2.80, 3.83) | 2.96 (2.51, 3.80) | 0.022* |
D-Dimer(< 500 μg/l FEU), median (IQR) |  | 390.0 (300.0, 630.0) | 490.0 (300.0, 1130.0) | 0.023* |
GPT(U/L), median (IQR) | Â | 18.0 (13.0,29.0) | 17.0 (13.0,27.0) | 0.609 |
GOT(U/L), median (IQR) | Â | 22.0 (19.0,27..8) | 23.0 (18.0,28.5) | 0.813 |
Serum Potassium, median (mmol/l)(IQR) | Â | 3.72 (3.48,3.89) | 3.79 (3.37,3.95) | 0.997 |
Blood Glucose, median (mmol/l) (IQR) | Â | 5.22 (4.75,6.41) | 5.21 (4.66,7.27) | 0.760 |
BUN (mmol/l), median (IQR) | Â | 4.59 (3.67,5.61) | 5.00 (4.15,6.14) | 0.037* |
Serum creatinine (mmol/l),median (IQR) | Â | 58.0 (49.3,70.8) | 59.0 (47.8,71.5) | 0.784 |
Triglycerides (mmol/l), median (IQR) | Â | 1.31 (0.98,1.69) | 1.20 (0.87,1.57) | 0.098 |
LDL (mmol/l), median (IQR) | Â | 2.28 (1.77,2.97) | 2.10 (1.48,2.55) | 0.010 |
IMT, n (%) | Normal | 35 (34.7) | 42 (34.1) | 0.483 |
Thicken | 66 (65.3) | 81 (65.9) | Â | |
Carotid Stenosis, n (%) | Normal | 56 (55.4) | 42 (33.6) | < 0.001* |
Mild | 36 (35.7) | 47 (37.6) | Â | |
Moderate to Severe | 9 (8.9) | 36 (28.8) | Â | |
LVEF(%), n (%) | < 50 | 2 (2.2) | 6 (5.0) | 0.014* |
50 ~ 55 | 0 (0.0) | 3 (2.5) |  | |
55 ~ 60 | 14 (15.1) | 27 (22.3) |  | |
≥60 | 77 (82.8) | 85 (70.2) |  |